ONCOBIOME Trademark

Trademark Overview


On Wednesday, June 4, 2014, a trademark application was filed for ONCOBIOME with the United States Patent and Trademark Office. The USPTO has given the ONCOBIOME trademark a serial number of 86300247. The federal status of this trademark filing is ABANDONED - EXPRESS as of Monday, October 2, 2017. This trademark is owned by VL28, Inc.. The ONCOBIOME trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

microbial preparations for pharmaceutical, veterinary and medical purposes, namely, microbial preparations for use as tumor suppressing agents, immuno-suppressing agents, immuno-stimulating agents, and anti-cancer agents; dietary supplements, nutritional supplements, nutraceuticals for use as dietary supplements, food supplements, nutritionally fortified vegetable-based food, beverages, and nutritional food bars, all of the foregoing containing microorganisms for medical, therapeutic, or preventative purposes; therapeutic pharmaceuticals containing microorganisms for medical and veterinary use for the treatment and prevention of pre-neoplastic lesions, neoplasms, tumors, cancers, and metastases; therapeutic pharmaceuticals containing derivatives of microorganisms for medical and veterinary use for the treatment and prevention of pre-neoplastic lesions, neoplasms, tumors, cancers, and metastases; pharmaceutical, veterinary and medical preparations and substances, namely, anti-microbial ...

scientific, analytical, and statistical computer software for creating and managing databases containing genomic, metagenomic, proteomic, transcriptomic, epigenetic, and metabolomic data derived from patient clinical care information and medical research data; computer software for analyzing and creating statistical models derived from patient clinical care information and medical research data in the nature of genomic, metagenomic, proteomic, transcriptomic, epigenetic, and metabolomic data

medical diagnostic instruments for screening, assessing, and determining appropriate courses of treatment in relation to pre-neoplastic lesions, neoplasms, tumors, cancers and metastases

electronic data storage services, namely, electronic storage of large-scale genomic, metagenomic, proteomic, transcriptomic, epigenetic, and metabolomic data and related clinical data for treatment and diagnostic purposes; database, computer-readable program and software development services, namely, development of scientific, analytical, and statistical software and related databases for use in conjunction with genomic, metagenomic, proteomic, transcriptomic, epigenetic, and metabolomic data gathered from patient clinical care information and medical research data; scientific, chemical, biochemical and microbiological research; scientific research in the field of genetics and genetic engineering of microbes; scientific research in the field of genetic and molecular tests, including tests for microbial populations in vertebrate samples; research and development of therapeutic pharmaceuticals, consumer medical products, diagnostic equipment and prognostic tools consisting of genetically...

medical clinics; veterinary dentistry; behavioural analysis for medical purposes; genetic testing for medical purposes; collection and preservation of human blood for medical purposes; medical diagnostic testing for assessing pre-neoplastic lesions, neoplasms, tumors, cancers, or metastases
oncobiome

General Information


Serial Number86300247
Word MarkONCOBIOME
Filing DateWednesday, June 4, 2014
Status601 - ABANDONED - EXPRESS
Status DateMonday, October 2, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicesmicrobial preparations for pharmaceutical, veterinary and medical purposes, namely, microbial preparations for use as tumor suppressing agents, immuno-suppressing agents, immuno-stimulating agents, and anti-cancer agents; dietary supplements, nutritional supplements, nutraceuticals for use as dietary supplements, food supplements, nutritionally fortified vegetable-based food, beverages, and nutritional food bars, all of the foregoing containing microorganisms for medical, therapeutic, or preventative purposes; therapeutic pharmaceuticals containing microorganisms for medical and veterinary use for the treatment and prevention of pre-neoplastic lesions, neoplasms, tumors, cancers, and metastases; therapeutic pharmaceuticals containing derivatives of microorganisms for medical and veterinary use for the treatment and prevention of pre-neoplastic lesions, neoplasms, tumors, cancers, and metastases; pharmaceutical, veterinary and medical preparations and substances, namely, anti-microbial preparations and substances, anti-bacterial, anti-fungal, anti-viral, and anti-protist preparations and substances, all for the treatment of cancer, cancer symptoms, cancer-related diseases, and side-effects of cancer therapies; anti-cancer preparations and substances; preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals, namely, combination preparations containing in majority part antimicrobial preparations and lesser amounts of microbial preparations and anti-cancer preparations for use as a preservative; pharmaceutical preparations and substances for the treatment of cancer, namely, microbial and anti-microbial preparations for veterinary and medical use; anti-cancer preparations for use in treating cancer symptoms, cancer-related diseases, and side-effects of cancer therapies; pharmaceutical preparations for the treatment of infectious diseases and cancer, namely, combination preparations of anti-cancer agents, microbial preparations and anti-microbial preparations; diagnostic kits for diagnosing disease, determination of likelihood of disease, prognosis of responsiveness to therapy and/or patient prognosis comprised of diagnostic reagents and buffers for the detection of microbes, viral, bacterial, fungal, and parasitic or non-parasitic protist infections, inflammation, and biomarkers associated with pre-neoplastic lesions, neoplasms, tumors, cancers, or metastases; preparations for detecting mutations in genes for medical purposes as used in the collection of large-scale genomic, metagenomic, proteomic, transcriptomic, epigenetic, and metabolomic medical data and related clinical data
Goods and Servicesscientific, analytical, and statistical computer software for creating and managing databases containing genomic, metagenomic, proteomic, transcriptomic, epigenetic, and metabolomic data derived from patient clinical care information and medical research data; computer software for analyzing and creating statistical models derived from patient clinical care information and medical research data in the nature of genomic, metagenomic, proteomic, transcriptomic, epigenetic, and metabolomic data
Goods and Servicesmedical diagnostic instruments for screening, assessing, and determining appropriate courses of treatment in relation to pre-neoplastic lesions, neoplasms, tumors, cancers and metastases
Goods and Serviceselectronic data storage services, namely, electronic storage of large-scale genomic, metagenomic, proteomic, transcriptomic, epigenetic, and metabolomic data and related clinical data for treatment and diagnostic purposes; database, computer-readable program and software development services, namely, development of scientific, analytical, and statistical software and related databases for use in conjunction with genomic, metagenomic, proteomic, transcriptomic, epigenetic, and metabolomic data gathered from patient clinical care information and medical research data; scientific, chemical, biochemical and microbiological research; scientific research in the field of genetics and genetic engineering of microbes; scientific research in the field of genetic and molecular tests, including tests for microbial populations in vertebrate samples; research and development of therapeutic pharmaceuticals, consumer medical products, diagnostic equipment and prognostic tools consisting of genetically engineered microorganisms, combinations of microorganisms, and individually selected microorganisms for treatment and prevention of pre-neoplastic lesions, neoplasms, tumors, cancers and metastases
Goods and Servicesmedical clinics; veterinary dentistry; behavioural analysis for medical purposes; genetic testing for medical purposes; collection and preservation of human blood for medical purposes; medical diagnostic testing for assessing pre-neoplastic lesions, neoplasms, tumors, cancers, or metastases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 1, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateWednesday, April 1, 2015
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, April 1, 2015
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 19, 2014
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 1, 2015
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEVELO THERAPEUTICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02139

Party NameVL28, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Monday, October 2, 2017ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT
Monday, October 2, 2017ABANDONMENT - EXPRESS MAILED
Thursday, September 21, 2017EXPARTE APPEAL TERMINATED
Thursday, September 21, 2017EXPARTE APPEAL DISMISSED AS MOOT
Friday, July 21, 2017NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Friday, July 21, 2017ACTION DENYING REQ FOR RECON E-MAILED
Friday, July 21, 2017ACTION CONTINUING FINAL - COMPLETED
Monday, July 3, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 3, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 29, 2017TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, June 29, 2017EX PARTE APPEAL-INSTITUTED
Thursday, June 29, 2017JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, June 29, 2017EXPARTE APPEAL RECEIVED AT TTAB
Thursday, December 29, 2016NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, December 29, 2016FINAL REFUSAL E-MAILED
Thursday, December 29, 2016FINAL REFUSAL WRITTEN
Tuesday, December 6, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 5, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 5, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 3, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 3, 2016NON-FINAL ACTION E-MAILED
Friday, June 3, 2016NON-FINAL ACTION WRITTEN
Friday, May 13, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 13, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 13, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 13, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 13, 2015NON-FINAL ACTION E-MAILED
Friday, November 13, 2015NON-FINAL ACTION WRITTEN
Wednesday, November 4, 2015AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, October 26, 2015APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 26, 2015TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 23, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 22, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 22, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 22, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 22, 2015NON-FINAL ACTION E-MAILED
Wednesday, April 22, 2015NON-FINAL ACTION WRITTEN
Wednesday, April 1, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 1, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 30, 2015ASSIGNED TO LIE
Saturday, March 21, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 2, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 2, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 23, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 23, 2014NON-FINAL ACTION E-MAILED
Tuesday, September 23, 2014NON-FINAL ACTION WRITTEN
Tuesday, September 16, 2014ASSIGNED TO EXAMINER
Thursday, June 19, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM